Search Results - PHARMACEUTICAL INDUSTRY PRACTICE

1

EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D

by Kay Warner, Wolf See, David Haerry, Ingrid Klingmann, Amy Hunter, Matthew May
Published 2018-10-01

Subjects: “...pharmaceutical industry-led medicines R&D...”

Get full text

Article

2

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials

by Ingrid Klingmann, Andrea Heckenberg, Kay Warner, David Haerry, Amy Hunter, Matthew May, Wolf See
Published 2018-09-01

“... areas of indications—today is a widely accepted strategy in pharmaceutical industry to ensure relevance...”

Get full text

Article

3

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes

by David Haerry, Cordula Landgraf, Kay Warner, Amy Hunter, Ingrid Klingmann, Matthew May, Wolf See
Published 2018-08-01

“...) was to close this gap through the development of guidance documents for pharmaceutical industry-led medicines R...”

Get full text

Article

4

EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment

by Amy Hunter, Amy Hunter, Karen Facey, Karen Facey, Victoria Thomas, Victoria Thomas, David Haerry, David Haerry, Kay Warner, Kay Warner, Ingrid Klingmann, Ingrid Klingmann, Matthew May, Matthew May, Wolf See, Wolf See
Published 2018-09-01

“... in pharmaceutical industry-led research and development, ethics committees, and regulatory authorities. The guidance...”

Get full text

Article

Narrow Search